Pharma is a ‘no-brainer trade’ for 2026, says Sandeep Tandon

Investor focus shifts from momentum to valuation and liquidity amid market churn. Quant Mutual Fund's CIO Sandeep Tandon advises avoiding frothy Q-commerce stocks, favoring undervalued traditional companies. He sees pharmaceuticals as a strong, long-term 'no-brainer' bet with limited downside and significant upside.